AzTrials
AzTrials

Rheumatoid Arthritis (RA)RANCT07487779

Efficacy of Structured Progressive Training Exercise on Muscle Strength of Patients With Rheumatoid Arthritis

A study testing Progressive Resistance Training in people with Rheumatoid Arthritis (RA), run by Kufa University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to find out if a specific exercise program helps patients with Rheumatoid Arthritis (RA). RA is a chronic autoimmune disease that causes pain, weakness, and reduced function in the joints and muscles. While medication is common, exercise is also important for management. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Rheumatoid Arthritis (RA)
What is being tested?
Progressive Resistance Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
118 participants
Where
No sites listed yet
Study dates
1 Apr 2026to 1 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed with Rheumatoid Arthritis according to American College of Rheumatology criteria
  • Age 18-65 years
  • Both genders eligible
  • Disease duration of at least 6 months
  • Stable medication regimen for at least 3 months before study
  • Mild to moderate disease activity
Show all 10Show fewer
  • Able to walk independently with or without assistive devices
  • Willing and able to provide informed consent
  • Agree to participate in the exercise program for 6 weeks
  • Attending AL-Najaf Teaching Hospital for RA management

Who cannot join

  • Severe cardiovascular disease (unstable angina, recent MI, severe heart failure)
  • Other inflammatory arthritis (psoriatic arthritis, ankylosing spondylitis, lupus)-
  • Recent joint surgery or fracture within the past 6 months
  • Severe osteoporosis with fracture risk
  • Pregnancy
  • Severe cognitive impairment preventing participation
Show all 11Show fewer
  • Uncontrolled hypertension (BP >180/110 mmHg)
  • Active infection or fever at baseline
  • Severe joint damage preventing exercise participation
  • Participation in another exercise program during the study period
  • Neuromuscular disorders affecting muscle function

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Mohammed Hakim Shamran contact

+9647809417841

muhammedh.alhjem@uokufa.edu.iq

About this study

This study aims to find out if a specific exercise program helps patients with Rheumatoid Arthritis (RA). RA is a chronic autoimmune disease that causes pain, weakness, and reduced function in the joints and muscles. While medication is common, exercise is also important for management.

The study will test a program called "Progressive Resistance Training." About 118 adult patients with RA at AL-Najaf Teaching Hospital will participate. They will be divided into two groups. One group will perform specific resistance exercises for six weeks, while the other group will continue their usual care without this specific training.

The researchers will measure muscle strength, cardiovascular function, and energy levels before and after the six-week program. The goal is to determine if this exercise improves muscle strength and helps patients perform daily activities more efficiently. The study hopes to show that resistance training is a safe and effective way to improve quality of life for people with RA.

Being tested
Progressive Resistance Training
Medical subject headings
Arthritis, Rheumatoid

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Progressive Resistance TrainingOther

    Progressive Resistance Training (PRT) program for patients with Rheumatoid Arthritis. The intervention consists of supervised resistance exercises targeting major muscle groups of upper and lower extremities.

    Program Details:

    • Duration: 6 weeks
    • Frequency: 3 sessions per week
    • Session duration: 45-60 minutes
    • Setting: AL-Najaf Teaching Hospital

    Exercise Components:

    • Warm-up exercises (10 minutes)
    • Resistance training using resistance bands, light weights, and body weight exercises (30-40 minutes)
    • Cool-down and stretching (10 minutes)

    Progression Method:

    • Intensity starts at 40-50% of maximum capacity
    • Gradually increases to 60-70% over 6 weeks
    • Repetitions: 8-12 per set
    • Sets: 2-3 sets per exercise
    • Exercises adjusted based on individual tolerance and disease activity

    Supervision: Trained physical therapist/nurse supervision with regular monitoring of pain levels, fatigue, and joint swelling.

    The program is designed specifically for RA patients with mild to moderate

Study groups in NCT07487779
Study groupRoleWhat they receive
Progressive Resistance Training GroupActive comparatorParticipants in this group will receive a supervised Progressive Resistance Training (PRT) program for 6 weeks. The intervention includes: * Resistance exercises 3 times per week * Sessions lasting 45-60 minutes each * Exercises targeting major muscle groups of upper and lower extremities * Use of resistance bands, light weights, and body weight exercises * Progressive intensity starting at 40-50% and increasing to 60-70% of maximum capacity * 8-12 repetitions per set, 2-3 sets per exercise * Supervised by trained physical therapist at AL-Najaf Teaching Hospital * Regular monitoring of pain, fatigue, and disease activity The program is designed to improve muscle strength in patients with Rheumatoid Arthritis while maintaining safety and avoiding disease exacerbation.
Receives: Other: Progressive Resistance Training
Control Group - Standard CareNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Muscle Strength from Baseline to 6 Weeks

    Muscle strength will be measured using manual muscle testing or dynamometer for upper and lower extremities

    Measured: Baseline and 6 weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2026
  2. Study start1 Apr 2026 (estimated)
  3. Primary completion1 May 2026 (estimated)
  4. Study completion1 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
118 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07487779
Sponsor's protocol ID
Kufa-2026-01
Acronym
RA
Status last verified
Mar 2026
First submitted
17 Mar 2026
Last updated
1 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Progressive Resistance Training in people with Rheumatoid Arthritis (RA), run by Kufa University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mohammed Hakim Shamran (+9647809417841, muhammedh.alhjem@uokufa.edu.iq), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Muscle Strength from Baseline to 6 Weeks (time frame: Baseline and 6 weeks post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in